Three major drug distributors have proposed paying $10 billion to settle claims that they played a role in fuelling the US’ opioid epidemic by downplaying risks and flooding the market with pills – but plaintiffs want much more. It’s the first time in two years of discussions that the three companies – McKesson Corp., Cardinal Health Inc. and AmerisourceBergen Corp. – have put a figure on the table in an attempt to resolve the lawsuits against them, Bloomberg reported. The companies reportedly made a verbal proposal during ongoing talks – but the National Association of Attorneys General, which is handling the discussions on behalf of more than 35 states, countered the offer with a demand for $45 billion to help solve the public health crisis of opioid addiction. A McKesson spokeswoman denied that a settlement offer had been made, but Bloomberg’s sources said that there had indeed been an opening offer. AmerisourceBergen and Cardinal Health declined to comment.
Source: Drop in the bucket: US pharmaceutical giants propose $10B settlement to resolve opioid lawsuits